It was reported that patients with uremia have larger total plasma concentration of ropivacaine and its main metabolites after brachial plexus block compared to those without uremia.[9] Ropivacaine and lidocaine are highly bound to α1-acid glycoprotein (AAG), which is increased in uremic patients and provides protection against LAST. This evidence concerns the gene MPG and uremia.